- Home
- RELL vs CRVO Comparison
RELL vs CRVO Comparison
Compare RELL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- CRVO
- Stock Information
- Founded
- RELL 1947
- CRVO 2001
- Country
- RELL United States
- CRVO United States
- Employees
- RELL N/A
- CRVO N/A
- Industry
- RELL Electronic Components
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- CRVO Health Care
- Exchange
- RELL Nasdaq
- CRVO Nasdaq
- Market Cap
- RELL 166.3M
- CRVO 160.4M
- IPO Year
- RELL N/A
- CRVO N/A
- Fundamental
- Price
- RELL $11.84
- CRVO $19.17
- Analyst Decision
- RELL
- CRVO Strong Buy
- Analyst Count
- RELL 0
- CRVO 4
- Target Price
- RELL N/A
- CRVO $58.25
- AVG Volume (30 Days)
- RELL 47.3K
- CRVO 79.5K
- Earning Date
- RELL 10-09-2024
- CRVO 11-11-2024
- Dividend Yield
- RELL 2.04%
- CRVO N/A
- EPS Growth
- RELL N/A
- CRVO N/A
- EPS
- RELL 0.00
- CRVO N/A
- Revenue
- RELL $196,460,000.00
- CRVO $9,653,281.00
- Revenue This Year
- RELL $14.22
- CRVO $47.04
- Revenue Next Year
- RELL $13.00
- CRVO N/A
- P/E Ratio
- RELL $2,775.73
- CRVO N/A
- Revenue Growth
- RELL N/A
- CRVO 585.67
- 52 Week Low
- RELL $8.08
- CRVO $4.28
- 52 Week High
- RELL $14.30
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- RELL 52.12
- CRVO 55.34
- Support Level
- RELL $11.39
- CRVO $14.83
- Resistance Level
- RELL $11.73
- CRVO $17.43
- Average True Range (ATR)
- RELL 0.22
- CRVO 1.76
- MACD
- RELL -0.01
- CRVO 0.04
- Stochastic Oscillator
- RELL 41.11
- CRVO 73.22
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.